You are here

Article metrics

Article menu
Clinical/translational cancer immunotherapy
Original research
Pembrolizumab and decitabine for refractory or relapsed acute myeloid leukemia

 

Online download statistics by month:

Online download statistics by month: January 2022 to February 2026

AbstractFullPdf
Jan 2022769784227
Feb 2022336341102
Mar 2022230235110
Apr 202218118785
May 202217517890
Jun 202223625397
Jul 202223424567
Aug 202226426880
Sep 202220320664
Oct 202222823253
Nov 202219819856
Dec 202217117156
Jan 202317117666
Feb 202316616747
Mar 202316516759
Apr 2023145146116
May 202315215263
Jun 202314915062
Jul 202312112253
Aug 202314114258
Sep 202311211351
Oct 202312913146
Nov 202311111143
Dec 2023929336
Jan 2024616336
Feb 2024707139
Mar 202413013676
Apr 202410410446
May 2024888931
Jun 2024878840
Jul 202412412540
Aug 2024121120109
Sep 202416516654
Oct 202412212237
Nov 202413013248
Dec 202414314935
Jan 202510711250
Feb 202528628750
Mar 202510910944
Apr 202514814865
May 2025979853
Jun 2025767736
Jul 2025110
Feb 2026110
Total704971662676